Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Total Current Liabilities (2023 - 2025)

Camp4 Therapeutics' Total Current Liabilities history spans 3 years, with the latest figure at $15.5 million for Q4 2025.

  • For Q4 2025, Total Current Liabilities rose 61.64% year-over-year to $15.5 million; the TTM value through Dec 2025 reached $15.5 million, up 61.64%, while the annual FY2025 figure was $15.5 million, 61.64% up from the prior year.
  • Total Current Liabilities for Q4 2025 was $15.5 million at Camp4 Therapeutics, up from $7.9 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $15.5 million in Q4 2025 and bottomed at $6.4 million in Q1 2025.
  • The 3-year median for Total Current Liabilities is $8.8 million (2024), against an average of $9.8 million.
  • The largest YoY upside for Total Current Liabilities was 61.64% in 2025 against a maximum downside of 33.19% in 2025.
  • A 3-year view of Total Current Liabilities shows it stood at $7.8 million in 2023, then grew by 22.94% to $9.6 million in 2024, then soared by 61.64% to $15.5 million in 2025.
  • Per Business Quant, the three most recent readings for CAMP's Total Current Liabilities are $15.5 million (Q4 2025), $7.9 million (Q3 2025), and $6.4 million (Q1 2025).